Discovery of benzothiazine derivatives as novel, orally-active anti-epileptic drug candidates with broad anticonvulsant effect.

Bioorg Med Chem Lett

Drug Research Division, Sumitomo Dainippon Pharma Co., Ltd, 33-94 Enoki-cho, Suita, Osaka 564-0053, Japan.

Published: October 2015

In order to develop novel anti-epileptic drugs that are effective for both general and partial seizure, we conducted in vivo screening of our chemical library in the mice MES and sc-PTZ models and found the benzothiazine 1 as lead compound. Optimization of this compound led to the discovery of compound 7b, which showed potent anticonvulsant effect in the MES, scPTZ and rat amygdala kindling models. Since the chemical structure of 7b is different from that of any existing AED, it is suggested that 7b may have unique mechanism of action for relieving both partial and generalized epilepsy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2015.08.071DOI Listing

Publication Analysis

Top Keywords

discovery benzothiazine
4
benzothiazine derivatives
4
derivatives novel
4
novel orally-active
4
orally-active anti-epileptic
4
anti-epileptic drug
4
drug candidates
4
candidates broad
4
broad anticonvulsant
4
anticonvulsant order
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!